CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread [Phase 2]
Summary
Phase 2 open-label trial of nivolumab in advanced or metastatic cancers has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-17